Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Real-World Toxicity and Efficacy Profile of Enfortumab Vedotin With or Without Pembrolizumab in Ultra-Elderly Patients With Advanced Urothelial Carcinoma.
Journal: JCO oncology practice
Published: August 18, 2026
Patterns of immune-related adverse events in patients treated for various cancer types with immune checkpoint inhibitors.
Journal: Future oncology (London, England)
Published: December 21, 2025
De Novo high-volume metastatic prostate cancer with primary resistance to standard systemic therapy and exceptional response to PSMA-Lu177: A case report.
Journal: International cancer conference journal
Published: June 22, 2025
Vitamin D deficiency in prostate cancer: Prevalence in a sun-rich climate and influence of androgen deprivation therapy.
Journal: World journal of clinical oncology
Published: April 07, 2025
Safety Analysis of Co-Administration of Radiation Therapy with Enfortumab Vedotin Based Regimens in Metastatic Urothelial Carcinoma.
Journal: Clinical genitourinary cancer
Published: June 27, 2024
The Butterfly Flies - Practice Changing Results of PAPILLON, First Line Chemotherapy and Amivantamab for the Treatment of NSCLC Patients with EGFR Exon 20 Insertions.
Journal: Lung Cancer (Auckland, N.Z.)
Published: December 13, 2023
Circadian Clock Dysregulation and Prostate Cancer: A Molecular and Clinical Overview.
Journal: Clinical Medicine Insights. Oncology
Published: April 19, 2023
Durable Response after Repeat Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in a Patient with Extensive Mucinous Adenocarcinoma of the Appendix.
Journal: Diseases (Basel, Switzerland)
Published: January 31, 2023
Combination of Pembrolizumab and Stereotactic Body Radiation Therapy in Recurrent Metastatic Penile Squamous Cell Carcinoma: A Case Study.
Journal: Biomedicines
Published: October 07, 2022
Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent Immunotherapy.
Journal: American journal of clinical oncology
Published: September 14, 2022
Last Updated: 09/26/2026